Current price of a non-dividend-paying biotech stock
Course:- Financial Management
Reference No.:- EM13943003

Assignment Help
Assignment Help >> Financial Management

The current price of a non-dividend-paying biotech stock is $140 with a volatility of 25%. The risk-free rate is 4%. For a three-month time step: (a) What is the percentage up movement? (b) What is the percentage down movement? (c) What is the probability of an up movement in a risk-neutral world? (d) What is the probability of a down movement in a risk-neutral world? Use a two-step tree to value a six-month European call option and a six-month European put option. In both cases the strike price is $150.

Put your comment

Ask Question & Get Answers from Experts
Browse some more (Financial Management) Materials
What would be the maximum an investor should pay for the common stock of a firm that has a 2.5% annual growth rate and has just paid a dividend of $1.50 per year? The next div
A property is leased for $24,000 per year although market rents are currently $27,500 per year and are expected to increase by 2% per year. The property is expected to be sold
Under what circumstances, if any, is a tax basis taxpayer allowed to claim a deduction for a bad debt? An accrual basis tax payer? Please provide examples or support with your
Last year we budgeted $8,000 for electricity. We expect to the price per kilowatt hour (kWh) to go up from 6.5 cents per kWh to 7 cents per kWh. We have also recently implemen
A bond has a par value of $1,000, a time to maturity of 15 years, and a coupon rate of 9.00% with interest paid annually. If the current market price is $900, what will be the
What is the price you are willing to pay for the stock today if the share of stock offers zero dividends for the first five years a constant growth rate thereafter of 10% and
On average, D & M sells its inventory in 37 days, collects on its receivables in 3.4 days, and takes 35 days to pay for its purchases. What is the length of the firm’s operati
As an advisor, you must advise an individual named John about his investments. Assume his risk profile and his return objectives and explain (in detail) the recommended approp